TCT 2022 Highlights
81% Survival at 30 Days in a Multi-Center, Multi-Society Study of Impella®-Supported AMICS Patients in Japan
Junya Ako, MD, an interventional cardiologist and chair of the department of cardiovascular medicine at Kitasato University Hospital in Kanagawa, presented results of his new Japanese Registry for Percutaneous Ventricular Assist Devices (J-PVAD) study.
Saturday Lunch Symposium On-Demand: From Shock Spiral to Survival: Achieving Heart Recovery in Cardiogenic Shock
AMICS Outcomes from J-PVAD Study
Junya Ako, MD, presents outcomes in AMI cardiogenic shock from Japan's J-PVAD study.
Best Practices in Cardiogenic Shock
Katherine Kunkel, MD, discusses data-driven decision making and best practices in cardiogenic shock.
Cardiogenic Shock Working Group and SCAI Shock Stages
Navin Kapur, MD, provides an update from the Cardiogenic Shock Working Group and discusses the SCAI shock stages in this presentation.
Sunday Lunch Symposium On-Demand: The CAD’s Out of the Bag: Achieving Heart Recovery in High-Risk Revascularization
Part One: Influential Trials in High-Risk PCI: Shaping the Future of Ischemic Heart Failure Therapy
Jonathan Hill, MD, presents the influential high-risk PCI trials shaping the future of ischemic heart failure therapy.
Part Two: Percutaneous Mechanical Support for PCI in Surgically Ineligible Patients: Sub-Analysis Results from the OPTIMUM Study
Adam C. Salisbury, MD, MSc, explores the question: What is the association between prophylactic use of Impella® (“Protected PCI”) and clinical outcomes?
Part Three: The Impact of Unloading: What We May Learn from the STEMI DTU™ RCT
Navin Kapur, MD, presents lessons learned in the STEMI DTU™ pilot trial in this presentation.
Contemporary Practices for Impella-supported Complete Revascularization
Jonathan Hill, MD, discusses influential trials in high-risk PCI that are shaping the future of ischemic heart failure therapy.
Daily TCT Recaps
Live from TCT: Saturday, September 17, 2022
Seth Bilazarian, MD, and Chuck Simonton, MD, recap highlights from day one of TCT 2022 and interview Greg Stone, MD and Alaide Chieffo, MD, FESC.
Live from TCT: Sunday, September 18, 2022
This recap of highlights from day two of TCT 2022 includes interviews with Drs. Sanjit Jolly, Navin Kapur, Adrian Attinger-Toller and Taishi Hirai.
More Than 235,000 Patients Supported with Impella Heart Pumps
Impella heart pumps allow a heart team to achieve high-risk revascularization and heart recovery in the cath lab and OR. Impella heart pumps provide the unique benefit of unloading the heart while providing coronary perfusion and end organ perfusion.